Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Nov 29 02:53PM ET
0.8800
Dollar change
-0.0325
Percentage change
-3.56
%
Index- P/E- EPS (ttm)-0.67 Insider Own9.27% Shs Outstand30.33M Perf Week2.02%
Market Cap26.35M Forward P/E- EPS next Y-0.52 Insider Trans-0.32% Shs Float28.16M Perf Month-34.81%
Income-17.07M PEG- EPS next Q-0.02 Inst Own22.95% Short Float3.44% Perf Quarter-40.54%
Sales8.59M P/S3.07 EPS this Y58.61% Inst Trans-4.35% Short Ratio13.78 Perf Half Y-48.54%
Book/sh0.04 P/B22.44 EPS next Y-4.70% ROA-43.33% Short Interest0.97M Perf Year35.38%
Cash/sh0.35 P/C2.54 EPS next 5Y15.00% ROE-218.51% 52W Range0.48 - 1.88 Perf YTD49.15%
Dividend Est.- P/FCF- EPS past 5Y5.33% ROI-536.26% 52W High-53.19% Beta1.03
Dividend TTM- Quick Ratio0.60 Sales past 5Y-3.23% Gross Margin79.73% 52W Low82.95% ATR (14)0.12
Dividend Ex-Date- Current Ratio0.71 EPS Y/Y TTM63.71% Oper. Margin-225.06% RSI (14)32.36 Volatility12.82% 11.87%
Employees58 Debt/Eq11.26 Sales Y/Y TTM-6.53% Profit Margin-198.62% Recom1.67 Target Price6.75
Option/ShortYes / Yes LT Debt/Eq1.61 EPS Q/Q-1.17% Payout- Rel Volume1.24 Prev Close0.91
Sales Surprise-3.65% EPS Surprise14.27% Sales Q/Q10.49% EarningsNov 13 AMC Avg Volume70.27K Price0.88
SMA20-21.77% SMA50-29.53% SMA200-30.05% Trades Volume85,372 Change-3.56%
Date Action Analyst Rating Change Price Target Change
Oct-30-20Initiated Chardan Capital Markets Buy $7
Oct-12-20Initiated ROTH Capital Buy
Jul-31-20Initiated Oppenheimer Outperform $7
Jan-31-20Initiated B. Riley FBR Buy $5
Nov-18-19Resumed Cantor Fitzgerald Overweight
Sep-06-19Initiated Cantor Fitzgerald Overweight $5
Mar-06-18Upgrade H.C. Wainwright Neutral → Buy $3.50
Oct-20-17Reiterated Laidlaw Buy $3 → $2
Oct-20-17Downgrade Stifel Buy → Hold $3 → $0.90
Oct-20-17Downgrade H.C. Wainwright Buy → Neutral
Nov-25-24 06:00AM
Nov-14-24 07:49AM
02:15AM
Nov-13-24 05:10PM
04:08PM
04:01PM Loading…
04:01PM
Nov-06-24 04:45PM
Oct-17-24 08:30AM
Oct-09-24 06:19PM
Sep-25-24 08:00AM
Sep-04-24 04:30PM
Aug-13-24 05:15PM
04:08PM
04:01PM
Aug-07-24 04:30PM
09:40AM Loading…
Jun-19-24 09:40AM
May-21-24 11:17AM
08:00AM
May-14-24 01:21PM
11:44AM
08:20AM
03:03AM
May-13-24 08:54PM
05:20PM
04:17PM
04:05PM
May-07-24 04:30PM
Apr-30-24 07:00AM
Apr-01-24 02:11PM
Mar-27-24 08:53PM
05:10PM Loading…
05:10PM
04:19PM
04:01PM
Mar-20-24 04:30PM
Mar-04-24 07:00AM
Feb-07-24 06:48PM
Nov-14-23 08:05AM
Nov-13-23 04:40PM
04:05PM
Nov-09-23 04:30PM
Nov-08-23 08:40AM
07:59AM
Nov-07-23 04:01PM
Oct-19-23 10:44AM
Oct-02-23 03:07PM
Sep-07-23 07:00AM
Aug-31-23 04:30PM
Aug-14-23 07:55AM
Aug-10-23 07:08AM
Aug-09-23 05:50PM
04:43PM
04:05PM
Aug-03-23 04:30PM
Jul-28-23 04:19PM
Jul-20-23 08:00AM
Jun-07-23 06:00AM
May-11-23 09:55AM
May-08-23 05:25PM
04:23PM
04:05PM
May-01-23 07:03PM
Apr-27-23 05:11PM
Apr-25-23 06:45PM
Apr-10-23 06:00AM
Mar-24-23 06:30AM
Mar-21-23 04:30PM
Mar-11-23 07:33AM
Mar-09-23 08:30AM
Mar-08-23 05:53AM
Mar-07-23 05:35PM
04:05PM
Feb-28-23 06:07PM
Feb-17-23 06:30AM
Feb-03-23 05:17PM
Jan-11-23 07:59AM
Nov-28-22 06:46PM
Nov-02-22 06:05PM
04:05PM
Oct-26-22 08:30AM
Oct-06-22 08:30AM
Sep-26-22 08:30AM
Sep-06-22 08:00AM
Aug-08-22 06:09AM
Aug-04-22 07:35PM
04:05PM
Jul-27-22 04:15PM
Jul-24-22 08:41AM
Jul-15-22 06:15AM
Jul-05-22 08:30AM
Jun-18-22 08:05AM
May-31-22 06:21AM
May-18-22 01:53PM
May-08-22 08:19AM
May-04-22 06:25PM
04:05PM
Apr-27-22 04:15PM
Mar-24-22 09:30AM
Mar-23-22 04:15PM
01:29PM
Mar-09-22 04:30PM
DURECT Corp. focuses on advancing novel and potentially lifesaving investigational therapies derived from its Epigenetic Regulator Program. Its pipeline is called DUR-928, an endogenous sulfated oxysterol and an epigenetic regulator. The company was founded by James E. Brown and Felix Theeuwes on February 6, 1998 and is headquartered in Cupertino, CA.